home / stock / ptla / ptla quote
Last: | $18.03 |
---|---|
Change Percent: | 0.22% |
Open: | $18 |
Close: | $18.03 |
High: | $18.07 |
Low: | $17.99 |
Volume: | 8,075,249 |
Last Trade Date Time: | 07/01/2020 04:55:56 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$18.03 | $18 | $18.03 | $18.07 | $17.99 | 8,075,249 | 07-01-2020 |
$17.99 | $17.98 | $17.99 | $17.99 | $17.97 | 1,491,578 | 06-30-2020 |
$17.97 | $17.96 | $17.97 | $17.99 | $17.96 | 1,587,935 | 06-29-2020 |
$17.97 | $17.96 | $17.97 | $17.98 | $17.96 | 2,075,475 | 06-26-2020 |
$17.98 | $17.97 | $17.98 | $17.98 | $17.95 | 1,460,255 | 06-25-2020 |
$17.95 | $17.94 | $17.95 | $17.97 | $17.94 | 865,286 | 06-24-2020 |
$17.95 | $17.96 | $17.95 | $17.97 | $17.94 | 1,676,551 | 06-23-2020 |
$17.96 | $17.92 | $17.96 | $17.97 | $17.92 | 3,396,434 | 06-22-2020 |
$17.91 | $17.94 | $17.91 | $17.95 | $17.9 | 2,433,718 | 06-19-2020 |
$17.94 | $17.94 | $17.94 | $17.96 | $17.92 | 1,150,202 | 06-18-2020 |
$17.94 | $17.93 | $17.94 | $17.96 | $17.93 | 1,429,523 | 06-17-2020 |
$17.94 | $17.96 | $17.94 | $17.96 | $17.93 | 1,051,031 | 06-16-2020 |
$17.94 | $17.93 | $17.94 | $17.96 | $17.92 | 2,110,216 | 06-15-2020 |
$17.92 | $17.9 | $17.92 | $17.9247 | $17.9 | 185,871 | 06-11-2020 |
$17.94 | $17.91 | $17.94 | $17.95 | $17.91 | 1,277,590 | 06-10-2020 |
$17.91 | $17.92 | $17.91 | $17.935 | $17.89 | 1,594,462 | 06-09-2020 |
$17.9 | $17.91 | $17.9 | $17.93 | $17.9 | 2,266,338 | 06-08-2020 |
$17.91 | $17.94 | $17.91 | $17.95 | $17.91 | 1,594,365 | 06-05-2020 |
$17.92 | $17.9 | $17.92 | $17.95 | $17.9 | 1,484,009 | 06-04-2020 |
$17.93 | $17.94 | $17.93 | $17.96 | $17.89 | 3,478,932 | 06-03-2020 |
News, Short Squeeze, Breakout and More Instantly...
Portola Pharmaceuticals Inc. Company Name:
PTLA Stock Symbol:
NASDAQ Market:
Portola Pharmaceuticals Inc. Website:
SOUTH SAN FRANCISCO, Calif. , May 18, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of stockholders, employees and othe...
SOUTH SAN FRANCISCO, Calif. , May 14, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has proposed extending the New Technology Add-on Payment (NTAP) for Andexxa ® [coagula...
SOUTH SAN FRANCISCO, Calif. , May 11, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today reported financial results for the three months ended March 31, 2020, and provided a corporate update, including the Company's actions to continue to su...